Preparation and characterization of highly porous, biodegradable polyurethane scaffolds for soft tissue applications.

In the engineering of soft tissues, scaffolds with high elastance and strength coupled with controllable biodegradable properties are necessary. To fulfill such design criteria we have previously synthesized two kinds of biodegradable polyurethaneureas, namely poly(ester urethane)urea (PEUU) and poly(ether ester urethane)urea (PEEUU) from polycaprolactone, polycaprolactone-b-polyethylene glycol-b-polycaprolactone, 1,4-diisocyanatobutane and putrescine. PEUU and PEEUU were further fabricated into scaffolds by thermally induced phase separation using dimethyl sulfoxide (DMSO) as a solvent. The effect of polymer solution concentration, quenching temperature and polymer type on pore morphology and porosity was investigated. Scaffolds were obtained with open and interconnected pores having sizes ranging from several mum to more than 150 microm and porosities of 80-97%. By changing the polymer solution concentration or quenching temperature, scaffolds with random or oriented tubular pores could be obtained. The PEUU scaffolds were flexible with breaking strains of 214% and higher, and tensile strengths of approximately 1.0 MPa, whereas the PEEUU scaffolds generally had lower strengths and breaking strains. Scaffold degradation in aqueous buffer was related to the porosity and polymer hydrophilicity. Smooth muscle cells were filtration seeded in the scaffolds and it was shown that both scaffolds supported cell adhesion and growth, with smooth muscle cells growing more extensively in the PEEUU scaffold. These biodegradable and flexible scaffolds demonstrate potential for future application as cell scaffolds in cardiovascular tissue engineering or other soft tissue applications.

[1]  A. Takahara,et al.  Effect of soft segment chemistry on the biostability of segmented polyurethanes. I. In vitro oxidation. , 1991, Journal of biomedical materials research.

[2]  R L Reis,et al.  A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: morphology, mechanical and degradation behaviour. , 2001, Biomaterials.

[3]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[4]  T. Park,et al.  Porous biodegradable polymeric scaffolds prepared by thermally induced phase separation. , 1999, Journal of biomedical materials research.

[5]  David J. Mooney,et al.  Synthesis and Properties of Biodegradable Polymers Used as Synthetic Matrices for Tissue Engineering , 1997 .

[6]  Shangtian Yang,et al.  Effects of Filtration Seeding on Cell Density, Spatial Distribution, and Proliferation in Nonwoven Fibrous Matrices , 2001, Biotechnology progress.

[7]  L. Johnson,et al.  Polyamines are necessary for normal expression of the transforming growth factor-beta gene during cell migration. , 1997, The American journal of physiology.

[8]  Y. Ikada,et al.  Porous polyurethane tubes as vascular graft. , 1993, Journal of applied biomaterials : an official journal of the Society for Biomaterials.

[9]  M. Kodama,et al.  Porous polyurethane vascular prostheses with variable compliances. , 1992, Journal of biomedical materials research.

[10]  G Ciardelli,et al.  Interactions of osteoblasts and macrophages with biodegradable and highly porous polyesterurethane foam and its degradation products. , 1996, Journal of biomedical materials research.

[11]  R. Storey,et al.  Hydrolyzable poly (ester-urethane) networks from L-lysine diisocyanate and D,L-lactide/ε-caprolactone homo- and copolyester triols , 1994 .

[12]  H. S. Kim,et al.  Thermal behaviour of poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) tri-block copolymers , 2001 .

[13]  Burak Erman,et al.  Electrospinning of polyurethane fibers , 2002 .

[14]  F. G. Evans,et al.  Strength of biological materials , 1970 .

[15]  J. Vacanti,et al.  In vitro degradation of porous poly(L-lactic acid) foams. , 2000, Biomaterials.

[16]  R. Langer,et al.  Biodegradable polymers as drug delivery systems , 1990 .

[17]  J. Heller Poly(Ortho Esters) , 1993 .

[18]  B. Toursarkissian,et al.  Regulation of polyamine synthesis and transport by fibroblast growth factor in aortic smooth muscle cells. , 1996, Growth factors.

[19]  C. M. Agrawal,et al.  Biodegradable polymeric scaffolds for musculoskeletal tissue engineering. , 2001, Journal of biomedical materials research.

[20]  Mark L. Benson,et al.  Isolation of vascular smooth muscle cells from a single murine aorta. , 2001, Methods in cell science : an official journal of the Society for In Vitro Biology.

[21]  L. Zhao Biodegradable polymers as drug delivery systems , 2004 .

[22]  Michael S Sacks,et al.  Synthesis, characterization, and cytocompatibility of elastomeric, biodegradable poly(ester-urethane)ureas based on poly(caprolactone) and putrescine. , 2002, Journal of biomedical materials research.

[23]  M. Sacks,et al.  Biodegradable poly(ether ester urethane)urea elastomers based on poly(ether ester) triblock copolymers and putrescine: synthesis, characterization and cytocompatibility. , 2004, Biomaterials.

[24]  K. Woodhouse,et al.  Elastomeric biodegradable polyurethane blends for soft tissue applications , 2002, Journal of Biomaterials Science. Polymer Edition.

[25]  M J Yaszemski,et al.  Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds. , 1997, Journal of biomedical materials research.

[26]  Y. Nakayama,et al.  Novel compliant and tissue-permeable microporous polyurethane vascular prosthesis fabricated using an excimer laser ablation technique. , 1996, Journal of biomedical materials research.

[27]  R Guidoin,et al.  Physicochemical characterization of a hydrophilic microporous polyurethane vascular graft. , 1987, Journal of biomedical materials research.

[28]  Stuart L. Cooper,et al.  Polyurethanes In Medicine , 1986 .

[29]  R C Eberhart,et al.  Fabrication and characterization of small-diameter vascular prostheses. , 1988, Journal of biomedical materials research.

[30]  D. Wise,et al.  Effect of polymer foam morphology and density on kinetics of in vitro controlled release of isoniazid from compressed foam matrices. , 1997, Journal of biomedical materials research.

[31]  J. Anglen,et al.  Polycaprolactone/glass bioabsorbable implant in a rabbit humerus fracture model. , 1997, Journal of biomedical materials research.

[32]  A. J. Pennings,et al.  High molecular weight polyurethanes and a polyurethane urea based on 1,4-butanediisocyanate , 1998 .

[33]  P. Ma,et al.  Microtubular architecture of biodegradable polymer scaffolds. , 2001, Journal of biomedical materials research.

[34]  Anthony Atala,et al.  Synthetic Biodegradable Polymer Scaffolds , 1997, Birkhäuser Boston.

[35]  H. Kim,et al.  Mechanical behavior of electrospun fiber mats of poly(vinyl chloride)/polyurethane polyblends , 2003 .

[36]  R. Verbeeck,et al.  Synthesis and thermal properties of poly(ethylene glycol)-poly(?-caprolactone) copolymers , 1998 .

[37]  P. Ma,et al.  Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. , 1999, Journal of biomedical materials research.

[38]  Robert Langer,et al.  Biodegradable Polymer Scaffolds for Tissue Engineering , 1994, Bio/Technology.

[39]  Pieter Buma,et al.  Tissue ingrowth and degradation of two biodegradable porous polymers with different porosities and pore sizes. , 2002, Biomaterials.

[40]  C. M. Agrawal,et al.  Effects of fluid flow on the in vitro degradation kinetics of biodegradable scaffolds for tissue engineering. , 2000, Biomaterials.